Advances in studies on pharmacokinetics of scutellarin and scutellarein.
- Author:
Jianming LIU
1
;
Yuqing XIONG
Author Information
1. Institute of Clinical Pharmacology, Medical College Nanchang University, Nanchang 330006, China. liujianming390@163.com
- Publication Type:Journal Article
- MeSH:
Animals;
Apigenin;
pharmacokinetics;
Flavonoids;
chemistry;
Glucuronates;
pharmacokinetics;
Humans
- From:
China Journal of Chinese Materia Medica
2009;34(24):3165-3168
- CountryChina
- Language:Chinese
-
Abstract:
Scutellarin is the major effective ingredient of breviscapine, which is widely used in the treatment of cardiovascular diseases and has a remarkable achievement. In recent years, more and more reseaches had focused on the pharmacokinetics of scutellarin and scutellarein. The article summarized the studies on pharmacokinetics of scutellarin and scutellarein have been performed by domestic and oversea scholars.
